In April 2022 the Anti-Doping Agency of Kenya (ADAK) has reported an anti-doping rule violation against the Athlete Esther Chesang Kakuri after her sample tested positive for the prohibited substance Triamcinolone acetonide.
Following notification a provisional suspension was ordered and the Athlete filed a statement in her defence. The case was referred to the Kenya Sports Disputes Tribunal and settled based on the parties' written submissions.
The Athlete accepted the test result and denied the intentional use of the substance. She stated, without corroborating evidence, that she underwent medical treatment in a hospital for her condition and had used prescribed medication.
The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.
The Panel deems that the Athlete failed to demonstrate that the violation was not intentional, nor how the substance had entered her system. She did not produce any medical document, neither provided any information about her doctors and the hospital she underwent treatment.
Therefore the Panel decides on 23 February 2023 to impose a 4 year period of inelibility on the Athlete, starting on the date of the provisional suspension, i.e. on 11 May 2022.
